Jane C.K. Fitch - Concepedia

Author

Jane C.K. Fitch

Also Known As

J C Fitch, J C K Fitch, J CK Fitch, J Fitch, J. C.K. Fitch, J. Fitch, J.C.K. Fitch, Jane C K Fitch, Jane C. K. Fitch, Jane C.K Fitch

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital University of Oklahoma Yale University Harvard University Alexion Pharmaceuticals (United States)

About

Jane C.K. Fitch is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	505
2	Immunology	3	3	337
3	Cardiothoracic Surgery	2	2	190
4	Health Sciences	1	1	14
5	Public Health	1	1	42

Jane C.K. Fitch

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes Bruce D. Spiess, David Royston, Jerrold H. Levy, Transfusion	2004	315
Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass Jane C.K. Fitch, Scott A. Rollins, Louis A. Matis, Circulation	1999	284
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. Christine S. Rinder, Henry M. Rinder, Brian R. Smith, Journal of Clinical Investigation InflammationThrombosisComplement SystemCytokineComplement Activation Contributes	1995	213
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass Stanton K. Shernan, Jane C.K. Fitch, Nancy A. Nussmeier, The Annals of Thoracic Surgery Cardiovascular DiseaseTotal MortalityCardiac Surgical PatientsImmunologyAnti-c5 Complement Antibody	2004	110
Individual Variations in the Fibrinolytic Response During and After Cardiopulmonary Bypass Wayne L. Chandler, Jane C.K. Fitch, M. Wall, Thrombosis and Haemostasis	1995	96
Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves James G. Ramsay, Stanton K. Shernan, Jane C.K. Fitch, Journal of Thoracic and Cardiovascular Surgery Cardiac SurgeryCardiac AnaesthesiaCardiovascular DiseaseCardiac MechanicNew Q Waves	2005	80
The Efficacy and Resource Utilization of Remifentanil and Fentanyl in Fast-Track Coronary Artery Bypass Graft Surgery: A Prospective Randomized, Double-Blinded Controlled, Multi-Center Trial Davy Cheng, Mark F. Newman, Peter C. Duke, Anesthesia & Analgesia	2001	76
Preliminary Report of the Effects of Complement Suppression With Pexelizumab on Neurocognitive Decline After Coronary Artery Bypass Graft Surgery Joseph P. Mathew, Stanton K. Shernan, William D. White, Stroke	2004	62
Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation Christine S. Rinder, Henry M. Rinder, Michael J. Smith, Journal of Thoracic and Cardiovascular Surgery	1999	51
The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes Junzo Chino, Christina M. Annunziata, Sushil Beriwal, Gynecologic Oncology Adaptive RadiotherapyRadiation MedicineCervical Cancer ManagementCervical CancerCervical Health	2020	42

Page 1